Cite
[Post-marketing safety surveillance of Diemailing Kudiezi injection: real world study in 30 233 cases].
MLA
Liao, Xing, et al. “[Post-Marketing Safety Surveillance of Diemailing Kudiezi Injection: Real World Study in 30 233 Cases].” Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica, vol. 42, no. 15, Aug. 2017, pp. 2857–63. EBSCOhost, https://doi.org/10.19540/j.cnki.cjcmm.20170705.011.
APA
Liao, X., Yu, D.-D., Xie, Y.-M., Zhang, Y.-L., He, Y., Zhang, Y., Liu, Y., Yi, D.-H., & Wang, Y.-Y. (2017). [Post-marketing safety surveillance of Diemailing Kudiezi injection: real world study in 30 233 cases]. Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica, 42(15), 2857–2863. https://doi.org/10.19540/j.cnki.cjcmm.20170705.011
Chicago
Liao, Xing, Dan-Dan Yu, Yan-Ming Xie, Yun-Ling Zhang, Yan He, Yin Zhang, Yan Liu, Dan-Hui Yi, and Yong-Yan Wang. 2017. “[Post-Marketing Safety Surveillance of Diemailing Kudiezi Injection: Real World Study in 30 233 Cases].” Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica 42 (15): 2857–63. doi:10.19540/j.cnki.cjcmm.20170705.011.